CUSIP 09203E105COMBDTXQ4 2025
33 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Nea Management Company, LLC | 4.45M | $10.81M |
| 2 | Vanguard Group Inc | 2.19M | $5.32M |
| 3 | Marshall Wace, LLP | 1.11M | $2.70M |
| 4 | Siren, L.L.C. | 1.05M | $2.54M |
| 5 | Arrowstreet Capital, Limited Partnership | 1.04M | $2.53M |
| 6 | Jane Street Group, LLC | 961.8K | $2.34M |
| 7 | Renaissance Technologies LLC | 949.7K | $2.31M |
| 8 | Blackrock, Inc. | 888.3K | $2.16M |
| 9 |
| 4 | Feb 14, 2025 | Bb Biotech AG | 13G/A | 15.1% | 8.52M | SEC |
| 5 | Nov 14, 2024 | T. Rowe Price Investment Management, Inc. | 13G/A | 19.0% | 10.73M | SEC |
| 6 | Nov 14, 2024 | Vestal Point Capital, LP | 13G | 8.9% | 5.03M | SEC |
| 7 | Nov 8, 2024 | Blackrock, Inc. | 13G | 6.2% | 3.50M | SEC |
| 8 | Oct 24, 2024 | Blackrock, Inc. | 13G | 6.2% | 3.50M | SEC |
| 9 | Aug 8, 2024 | Versant Venture Capital Vi, L.P. | 13D/A | 7.0% | 3.95M | SEC |
| 10 | Jul 10, 2024 | T. Rowe Price Investment Management, Inc. | 13G/A | 18.9% | 10.66M | SEC |
See the full Schedule 13D/13G history for Black Diamond Therapeutics I.
Unlock full history| Vestal Point Capital, LP |
| 870.0K |
| $2.11M |
| 10 | Dimensional Fund Advisors LP | 857.0K | $2.08M |